These overpriced airport battery chargers have been recalled for a fire risk
Approximately 8,520 of the power banks were sold in the US, plus an additional 6,400 in Canada, through the company's online store and airport vending machines between February 2023 and May 2025. Pricing varied between $46 and $65.
The recalled units can be identified by the iStore logo engraved on the front and the model number printed on the back. Some units may also have the iStore printed above the model number. The magnetic power banks also feature a USB-C port for charging them back up.
iStore warns consumers with a recalled unit to stop using the power bank immediately and properly dispose of it after submitting a claim for a refund by emailing two photos to recall@istore.co. One photo should feature the front of the power bank with 'recalled' written on it with a permanent marker, and the second should show the model number on the back. A copy of the purchase receipt is also being requested, but is not mandatory to receive a refund.
As we've recommended before, sticking to reputable and known brands can help reduce the risk of power bank overheating issues. However, brands like Anker or Ugreen aren't yet household names, and most consumers will probably assume that a power bank sold in an airport vending machine will be from a reputable company. Thousands of these power banks were purchased and potentially used on flights. Although the number of passengers who charged them while in the air was potentially low, there's good reason to be especially alarmed by this recall given the history with battery fires on planes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Ruotong Gao Featured in XYZ Media's 'Next Generation of Innovators' for Developing a Novel Molecular Imprinted Polymer for Electrochemical Sweat Sensor
Spotlighting a 'Next Generation Innovator': Ruotong Gao's Novel Molecular Imprinted Polymer for Electrochemical Sweat Sensor LOS ANGELES, July 18, 2025 (GLOBE NEWSWIRE) -- XYZ Media, a leader in digital storytelling at the intersection of education and innovation, is proud to announce the newest feature in its 'Next Generation of Innovators' series. This digital campaign spotlights young trailblazers creating innovative solutions to global challenges. The new feature highlights Ruotong Gao for developing a wearable electrochemical sweat sensor that uses synthetic molecularly imprinted polymers (MIPs) to detect cardiovascular biomarkers in real time. Gao's sensor, capable of nanomolar detection of L-arginine, offers a non-invasive and highly selective diagnostic platform for early-stage cardiovascular disease monitoring. "I drew my inspiration from what I felt could actually improve the patient experience," Gao explained. "Our current healthcare system typically revolves around treatment post-symptoms but could benefit tremendously from early biomarker-based detection of diseases." Gao's wearable sensor relies on highly selective synthetic antibodies — MIPs — he engineered to target L-arginine, a key cardiovascular biomarker. These specialized polymers enable precise amino acid detection in sweat, offering real-time, non-invasive insights into heart health without the need for invasive blood sampling. "There were many challenges I faced within my project, but the main one was the issue of synthesizing the MIPs," said Gao. "I addressed this with heavy optimization of my procedure and many repetitions, taking around several months to get a working result." The sensor is built with tiny platinum wires coated with a special conductive material, designed to comfortably adhere to the skin. It measures electrical changes in sweat using a method called electrochemical impedance spectroscopy. Gao's sensor also achieved nanomolar-level detection of L-arginine with high selectivity—demonstrating a threefold higher impedance signal compared to structurally similar amino acids such as lysine and citrulline. In today's world where cardiovascular diseases remain one of the leading causes of death, Gao's work leads to a future of personalized, real-time healthcare, where conditions like hypertension or atherosclerosis can be detected long before symptoms appear. "My hopes are that, in the future, everyone will have access to a more personalized system for medicine, allowing for point-of-care monitoring by healthcare professionals, early detection, and in general, a better understanding of the state of our bodies," Gao added. "Ruotong Gao sets the perfect example of what we look for in a 'Next Generation Innovator,'" stated Jordan Hayes, Director of Communications at XYZ Media. "Through combining chemistry, materials science, and biomedical design, Gao is making cardiovascular disease detection more simple, less expensive, more accessible for all patients." About XYZ Media: Founded in 2018, XYZ Media bridges education and technology to spotlight the next generation of change-makers. XYZ Media is dedicated to spotlighting the achievements of tomorrow's leaders driving change. With a keen focus on educational excellence and digital innovation, XYZ Media fosters a community where young minds are encouraged to challenge the status quo and develop solutions for a better tomorrow. To learn more information on XYZ Media's 'Next Generation of Innovators' series, please contact: Jordan HayesDirector of Communicationspr@ XYZ Disclaimer: This content is provided by XYZ Media. The statements, views, and opinions expressed in this column are solely those of the content provider. The information shared in this press release is not a solicitation for investment, nor is it intended as investment, financial, or trading advice. It is strongly recommended that you conduct thorough research and consult with a professional financial advisor before making any investment or trading decisions. Please conduct your own research and invest at your own risk. A photo accompanying this announcement is available at
Yahoo
an hour ago
- Yahoo
Bio-Techne's Quarterly Earnings Preview: What You Need to Know
Valued at a market cap of $8.1 billion, Bio-Techne Corporation (TECH) is a leading Minneapolis-based life sciences company that develops and supplies over 500,000 high-quality products, including reagents, diagnostic tools, and analytical instruments for research, bioprocessing, and clinical diagnostics. It is expected to announce its fiscal Q4 earnings on Wednesday, Aug. 6. Prior to this event, analysts project this biotechnology company to report a profit of $0.45 per share, down 8.2% from $0.49 per share in the year-ago quarter. The company has a promising trajectory of consistently beating Wall Street's bottom-line estimates in each of the last four quarters. More News from Barchart Insider Trading Alert: Here's Who Bought Nvidia and AMD Stock Before the U.S. Chip Deal with China Dear Tesla Stock Fans, Mark Your Calendars for July 23 As QuantumScape Hits New 2025 Highs, Should You Buy, Sell, or Hold QS Stock? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For the current year, analysts expect TECH to report EPS of $1.66, up 5.7% from $1.57 in fiscal 2024. Shares of TECH have declined 31.9% over the past 52 weeks, considerably trailing both the S&P 500 Index's ($SPX) 12.7% upstick, and the Health Care Select Sector SPDR Fund's (XLV) 11.8% loss over the same time frame. On May 7, TECH shares surged over 2% after reporting its Q3 results. The company reported robust earnings driven by solid demand across its core segments, particularly in cell and gene therapy tools, diagnostics, and proteomic solutions. Its revenue came in at $316.2 million, reflecting year-over-year growth, while adjusted earnings per share stood at $0.56, beating analyst estimates. Wall Street analysts are moderately optimistic about TECH's stock, with a "Moderate Buy" rating overall. Among 15 analysts covering the stock, ten recommend "Strong Buy," and five indicate 'Hold.' The mean price target for TECH is $64.92, which indicates a notable 21.8% potential upside from the current levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Bowtie Secures Series C Fundraising From Sun Life
New Funding Fuels Growth in Medical Insurance and Innovation in Preventive Healthcare HONG KONG, July 18, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer[1], is proud to announce securing up to US$70 million in its Series C funding round. Led by Sun Life Hong Kong Limited ("Sun Life"), this marks the largest funding round for digital health insurers in Asia with a direct-to-consumer model. Bowtie continues to lead in Hong Kong's digital insurance market, ranking first in the direct channel[2], and securing the 9th position across all distribution channels in terms of new individual non-single premium policies sold[3]. With over US$80 million in Annual Recurring Revenue ("ARR")[4] and more than 100% year-over-year growth, Bowtie is on track to exceed US$100 million ARR by 2025; In just six years, Bowtie has provided over US$16 billion in total protection amount for families in Hong Kong. Recognized as a top high-growth company in Asia by the Financial Times[5] and ranked number one in Hong Kong, Bowtie is positioned among the fastest-growing tech companies globally. The investment aligns with Sun Life's broader strategy to collaborate with innovative digital companies and enhance insurance accessibility. With Sun Life's continued support and backing, Bowtie will continue to operate under its current leadership as an associated company of Sun Life, with its own brand identity, distinctive culture and dedicated employee base. "Bowtie is simultaneously achieving larger scale and faster growth which validates our unique business model and reflects the public's strong trust in our commitment to treating customers fairly," said Michael Chan, CEO and Co-Founder of Bowtie. "Sun Life's continued partnership reinforces Bowtie's position as a mission-driven insurer, leveraging technology to better serve customers through simple and transparent products in a friendly digital setting. Going forward, Bowtie will continue to benefit from Sun Life's strong capital base and shared purpose of helping clients achieve lifetime financial security and live healthier lives. We are grateful for Sun Life's continued trust and support." Bowtie takes pride in its operational efficiency and policy economics, generating over US$100 million in protection amount per employee, US$500,000 ARR per employee, and maintaining the same level of strong unit economics despite the continued growth and scaling, reflecting strong pricing and marketing discipline together with exceptional customer retention. "These results demonstrate the ability of our digital model to deliver exceptional efficiency and impact to customers, especially as we scale. We're doubling down on our core strengths, focusing on agentic artificial intelligence, health innovation, and talent development. Our investments in these areas will further enhance the customer experience and keep us ahead of the curve." said Fred Ngan, Co-Founder of Bowtie. "Sun Life has been a long-term, committed partner to Bowtie for almost seven years. We're very pleased to strengthen this partnership to support the next phase of growth," said Clement Lam, CEO of Sun Life Hong Kong Limited. "At Sun Life, we believe in creating possibilities through innovation and creativity. Through our collaboration with Bowtie, we are combining cutting edge technology with deep insurance expertise, to set standards in delivering meaningful and innovative transformation within the Hong Kong health insurance industry." This strategic investment will enable Bowtie to achieve ambitious goals, including securing a top 5 position in medical insurance in Hong Kong, measured by the number of new medical insurance customers, scaling preventive healthcare initiatives, and expanding into international markets. The funding will further solidify Bowtie's role as a rising insurer and digital health leader. [1]Bowtie Life Insurance Company Limited is Hong Kong's very first virtual insurer authorized by the Insurance Authority under the fast track pilot scheme. [2]According to Insurance Authority's Provisional Statistics for Long Term Business 2024, in the fourth quarter of 2024, Bowtie Life ranked first in terms of the number of new individual non-single premium policies sold through Direct channel in Hong Kong. [3]According to Insurance Authority's Provisional Statistics for Long Term Business 2024, in the fourth quarter of 2024, Bowtie Life ranked in no.9 in terms of the number of new individual non-single premium policies sold through all channels in Hong Kong. [4]Data as of May 2025. [5]Bowtie is recognized by its No.1 ranking in Hong Kong and No. 65 placement in the Financial Times High-Growth Companies Asia-Pacific 2025 list: About Bowtie Bowtie Life Insurance Company Limited is an authorized life insurance company and Hong Kong's very first virtual insurer authorized by the Insurance Authority under the fast track pilot scheme. Its vision is to bridge the health protection gap and transform the way people access healthcare in Asia. Through digital technology, Bowtie makes health insurance more affordable and accessible for individuals and small-medium enterprises. To date, Bowtie has raised over HK$1.0 billion from Sun Life Financial and Mitsui & Co., providing more than HK$100 billion in protection amount to families. Learn more at About Sun Life Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of March 31, 2025, Sun Life had total assets under management of C$1.55 trillion. For more information, please visit Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF. Sun Life Financial Inc. is the holding company of Sun Life Assurance Company of Canada. Sun Life Hong Kong Limited is a wholly-owned subsidiary of Sun Life Assurance Company of Canada. View original content to download multimedia: SOURCE Bowtie Life Insurance Company Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
